Doxycycline - A role in ocular surface repair

British Journal of Ophthalmology

Volumn 88, Issue 5, 2004, Pages 619-625

  Smith, V A ^a   Cook, S D ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DOXYCYCLINE; GELATINASE A; GELATINASE B; INTERLEUKIN 1ALPHA; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CORNEA; CORNEA CELL; CORNEA EPITHELIUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STAINING; ZYMOGRAPHY;

ANTI-BACTERIAL AGENTS; CASPASE 3; CASPASES; CELL SURVIVAL; CELLS, CULTURED; CORNEAL STROMA; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; EPITHELIUM, CORNEAL; HUMANS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 1942517952     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.025551     Document Type: Article

References (41)

1. Carlini G. Bacteriological and clinical investigations of the activity of a new antibiotic, doxycycline. In: Proceedings of the 5th International Congress of Chemotherapy, Vienna. 1967:457-72.
2. Smith GN, Mickler EA, Hasty KA, et al. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: Relationship to structure of the enzyme. Arthritis Rheum 1999;42:1140-6.
3. Ryan ME, Usman A, Ramamurthy NS, et al. Excessive matrix metalloproteinase activity in diabetes: Inhibition by tetracycline analogues with zinc reactivity. Curr Med Chem 2001;8:305-16.
4. Nordstrom D, Lindy O, Lauhio A, et al. Anti-collagenolytic mechanism of action of action of doxycycline treatment in rheumatoid arthritis. Rheumatol Int 1998;17:175-80.
5. Golub LM, Sorsa T, Lee HM, et al. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis. J Clin Peridontol 1995;22:100-9.
6. Boyle JR, McDermott E, Crowther M, et al. Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg 1998;27:354-61.
7. Hanemaaijer R, Sorsa T, Konttinen YT, et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells: Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997;272:31504-9.
8. Hanemaaijer R, Visser H, Koolwijk P, et al. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res 1998;12:114-18.
9. Durson D, Kim MC, Solomon A, et al. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase -9, doxycycline and corticosteroids. Am J Ophthalmol 2001;132:8-13.
10. Solomon A, Rosenblatt M, Li D-Q, et al. Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest. Ophthalmol & Vis Sci 2000;41:2544-57.
11. Shlopov BV, Stuart JM, Gumanovskaya ML, et al. Regulation of cartilage collagenase by doxycycline. J Rheumatol 2001;28:835-42.
12. Kuzin II, Snyder JE, Ugine GD, et al. Tetracyclines inhibit activated B cell function. Int Immunol 2001;13:921-31.
13. Amin AR, Patel RN, Thakker GD, et al. Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracycline. FEBS Letters 1997;410:259-64.
14. D'Agostino P, Arcoleo F, Barbera C, et al. Tetracycline inhibits the nitric oxide synthase activity induced by endotoxin cultured murin macrophages. Eur J Pharmacol 1998;346:283-90.
15. Beekman B, Verzijl N, de Roos JADM, et al. Doxycycline inhibits collagen synthesis by bovine chondrocytes cultured in alginate. Biochem Biophys Res Com 1997;23:107-10.
16. Van der Laan, Molenaar E, Ronday K, et al. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial. J Rheumatol 2001;28:1967-74.
17. Hope-Ross MW, Chell PB, Kervick GN, et al. Oral tetracycline in the treatment of recurrent corneal erosions. Eye 1994;8:384-8.
18. Frucht-Pery J, Sagi E, Hemo I, et al. Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol 1993;116:88-92.
19. Culbertson WW, Huang AJ, Mandelboum SH, et al. Effective treatment of phlyctekeratoconjunctivitis with oral tetracycline. Ophthalmology 1993;100:1358-66.
20. Afonso A, Sobrin L, Monroy DC, et al. Tear fluid Gelatinase B correlates with II-1α concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 1999;40:2506-12.
21. Smith VA, Hoh HB, Easty DL. The role of ocular matrix-metalloproteinases in peripheral ulcerative keratitis. Br J Ophthalmol 1999;83:1376-83.
22. Unemori EN, Werb Z. Reorganisation of polymerised actin: A possible trigger for induction of procollagenase in fibroblasts cultured in and on collagen gels. J Cell Biol 1986;103:1021-31.
23. Smith VA, Rishmawi H, Hussein H, et al. Tear film matrix metalloproteinases and ocular disease. Br J Ophthalmol 2001;85:147-53.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
25. Schermer A, Galvin S, Sun T-T. Differentiation related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of cornea epithelial stem cells. J Cell Biol 1986;103:49-62.
26. Shapira L, Soskolne WA, Houri Y, et al. Protection against endotoxic shock and lipopolysaccharide induced local inflammation by tetracycline: Correlation with inhibition of cytokine secretion. Infect Immun 1996;64:825-8.
27. MacNaul KL, Chartrain N, Lark M, et al. Discoordinate expression of stromelysin, collagenase and tissue inhibitor of metalloproteinase-1 in rheumatoid human synovial fibroblasts: synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 1990;265:17238-45.
28. Rawdanowicz TJ, Hampton AL, Nagase H, et al. Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase A, gelatinase B and stromelysin and their differential regulation by interleukin-1 alpha and tumor necrosis factor -alpha. J Clin Endocrinol Metab 1994;79:530-6.
29. Hoh HB. Ph D Thesis, University of Bristol 1998.
30. Collier JE, Wilhelm SM, Eizen AZ, et al. H-ras oncogene-transformed bronchial epithelial cells (TB-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 1988;263:6579-87.
31. Goldberg GI, Marmer BL, Grant GA, et al. Human 72 kilodalton type IV collagenase forms a complex with tissue inhibitor of metalloproteinases designated TIMP-2. Proc Natl Acad Sci 1989;86:8207-11.
32. Howard EW, Bullen EC, Banda MJ. Regulation of the autoactivation of human 72 kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991;266:13064-9.
33. Smith VA, Easty DL. Matrix metalloproteinase-2: Involvement in keratoconus. Eu J Ophthalmol 2000;10:215-26.
34. Circolo A, Welgus HG, Pierce GF, et al. Differential regulation of the expression of proteinases/antiproteinases in fibroblasts. Effects of interleukin-1 and platelet-derived growth factor. J Biol Chem 1991;226:12283-8.
35. Fabuni RP, Baker AH, Murray EJ, et al. Divergent regulation by cytokines and growth factors of 95 kDa and 72kDa gelatinases and tissue inhibitors of metalloproteinases -1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J 1996;315:335-42.
36. Riley GP, Harrall RL, Watson PG, et al. Collagenase MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye 1995;9:703-18.
37. Eiferman RA, Carothers DJ, Yankeelov JA. Peripheral rheumatoid ulceration and evidence for conjunctival collagenase production. Am J Ophthalmol 1979;87:703-9.
38. Brown SI, Weller CA, Wasserman HE. Collagenolytic activity of alkali burned corneas. Arch Ophthalmol 1969;81:370-6.
39. Berman M, Leary R, Gage J. Latent collagenase in the ulcerating rabbit cornea. Exp Eye Res 1977;25:435-55.
40. Girard MT, Matsubara M, Fini ME. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci 1991;32:2441-54.
41. Girard MT, Matsubara M, Kublin C, et al. Stromal fibroblasts synthesise collagenase and stromelysin during long term tissue remodeling. J Cell Sci 1993;104:1001-11.